New oral anticoagulants: which one should my patient use?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 536-540

  Weitz, Jeffrey I ^a   Gross, Peter L ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; BLOOD CLOTTING FACTOR 10A; DABIGATRAN; DRUG DERIVATIVE; MORPHOLINE DERIVATIVE; RIVAROXABAN; THIOPHENE DERIVATIVE; THROMBIN; WARFARIN;

CHEMISTRY; CLINICAL TRIAL (TOPIC); DRUG ANTAGONISM; HEMATOLOGY; HUMAN; METHODOLOGY; ORAL DRUG ADMINISTRATION; REVIEW; THROMBOSIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS AS TOPIC; FACTOR XA; HEMATOLOGY; HUMANS; MORPHOLINES; THIOPHENES; THROMBIN; THROMBOSIS; WARFARIN;

EID: 84877685793     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.536.3798545     Document Type: Review

References (0)